theophylline has been researched along with Arterial Occlusive Diseases in 18 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spinella, G | 1 |
| Majorana, M | 1 |
| Creutzig, A | 1 |
| Dau, D | 1 |
| Alexander, K | 1 |
| Benignetti, G | 1 |
| Fabbri, F | 1 |
| Benvenuti, C | 1 |
| Saito, D | 1 |
| Steinhart, CR | 1 |
| Nixon, DG | 1 |
| Olsson, RA | 1 |
| Van Nueten, JM | 1 |
| Wellens, D | 1 |
| Mund-Hoym, WD | 1 |
| Keller, L | 1 |
| Landi, A | 1 |
| Bársony, J | 1 |
| Di Perri, T | 1 |
| Pasini, FL | 1 |
| Pecchi, S | 1 |
| De Franco, V | 1 |
| Damiani, P | 1 |
| Pasqui, AL | 1 |
| Capecchi, PL | 1 |
| Orrico, A | 1 |
| Materazzi, M | 1 |
| Domini, L | 1 |
| Raspanti, D | 1 |
| Cameli, AM | 1 |
| Trapani, M | 1 |
| Dorigo, D | 1 |
| Mazzotta, A | 1 |
| Negro, P | 1 |
| Grossmann, K | 1 |
| Knischka, A | 1 |
| Friedman, S | 1 |
| Golan, A | 1 |
| Shoenfeld, A | 1 |
| Goldman, J | 1 |
| Meyer, MP | 1 |
| Musil, HE | 2 |
| Kunert, W | 1 |
| Lietz, W | 1 |
| Brücknerová, O | 1 |
| Cascio, F | 1 |
| Rossano, C | 1 |
| Testasecca, D | 1 |
| Giugliano, F | 1 |
| Memé, E | 1 |
1 review available for theophylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Mechanisms of vasodilatation and antivasoconstriction.
Topics: Actins; Adrenergic alpha-Antagonists; Angiotensin II; Arterial Occlusive Diseases; Bradykinin; Calci | 1979 |
3 trials available for theophylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Intermittent C | 1983 |
[Conservative treatment of chronic arterial circulation disorders using a combination of adenosine, theophylline, and sodium nicotinate (ATN)].
Topics: Adenosine; Arterial Occlusive Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Nicotin | 1972 |
[Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
Topics: Adult; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Delayed-Action Prepar | 1973 |
14 other studies available for theophylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Transcutaneous oxygen pressure during intra-arterial infusions].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Infusions, Intra-Arterial; Ischemia; Leg; | 1984 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifyllin | 1983 |
Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia.
Topics: Adenosine Deaminase; Animals; Arterial Occlusive Diseases; Blood Pressure; Cardiomyopathies; Cattle; | 1981 |
[Chronic peripheral arterial circulation disorders. Experience with the management of chronic peripheral artertial circulation disorders using Complamine].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Male; Middle Aged; Nicotinic Acids; Theoph | 1978 |
The use of Xavin infusions in obliterating peripheral arterial disorders.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Drug Evaluation; Female; Huma | 1975 |
In vivo and in vitro evidence of an adenosine-mediated mechanism of calcium entry blocker activities.
Topics: Adenosine; Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Female; Flunarizine; | 1989 |
[Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Topics: Arterial Occlusive Diseases; Drug Evaluation; Follow-Up Studies; Humans; Intermittent Claudication; | 1987 |
[Intra-arterial therapy of arterial occlusive diseases of the extremities].
Topics: Actihaemyl; Adenosine Triphosphate; Anti-Bacterial Agents; Arterial Occlusive Diseases; Drug Therapy | 1987 |
Acute opthalmologic complications during the use of oral contraceptives.
Topics: Adult; Amino Alcohols; Arterial Occlusive Diseases; Contraceptives, Oral; Contraceptives, Oral, Synt | 1974 |
[Treatment of arterial, peripheral and cerebral circulatory disorders. Clinical results using intravenous infusions of complamine].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Hemodynamics; Hypercholesterolemia; Infusion | 1972 |
[Experiences with the treatment of peripheral vascular diseases with Xavin].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Female; Humans; Intermittent Claudic | 1973 |
[Complamin effect in relation to dosage and localisation of vessel occlusion].
Topics: Arterial Occlusive Diseases; Dose-Response Relationship, Drug; Humans; Leg; Nicotinic Acids; Theophy | 1973 |
[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Pressure; Chronic Disea | 1973 |
[New administration technic for 7,2-hydroxy-3-(N-hydroxyethyl-N-methylamino)-propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine). Shock-dose arterioclysis].
Topics: Aged; Aorta, Abdominal; Arterial Occlusive Diseases; Femoral Artery; Humans; Leg Ulcer; Male; Method | 1974 |